Pan-Cancer Analysis Shows <i>TP53</i> Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome

Previously, we have shown TGF-β-induced NOX4 expression is involved in the epithelial-to-mesenchymal transition (EMT), a process critical for cancer metastasis, and that wild-type (WT) and mutant (Mut) p53 have divergent effects on TGF-β induction of NOX4: WT-p53 suppresses whereas Mut-p53 augments...

Full description

Bibliographic Details
Main Authors: Wei Feng Ma, Howard E. Boudreau, Thomas L. Leto
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/2/235
_version_ 1797415192226693120
author Wei Feng Ma
Howard E. Boudreau
Thomas L. Leto
author_facet Wei Feng Ma
Howard E. Boudreau
Thomas L. Leto
author_sort Wei Feng Ma
collection DOAJ
description Previously, we have shown TGF-β-induced NOX4 expression is involved in the epithelial-to-mesenchymal transition (EMT), a process critical for cancer metastasis, and that wild-type (WT) and mutant (Mut) p53 have divergent effects on TGF-β induction of NOX4: WT-p53 suppresses whereas Mut-p53 augments NOX4 mRNA and protein production in several tumor cell models. We sought to validate and extend our model by analyzing whole-exome data of primary tumor samples in The Cancer Genome Atlas (TCGA). We constructed a Pan-Cancer dataset from 23 tumor types and explored <i>NOX4</i> expression patterns in relation to EMT and patient survival. NOX4 mRNA levels increase as a function of cancer progression in several cancers and correlate with Mut-p53 mRNA and genes involved in programs of EMT, cellular adhesion, migration, and angiogenesis. Tumor macrophages appear to be a source of NOX2, whose association with genetic programs of cancer progression emulate that of NOX4. Notably, increased <i>NOX4</i> expression is linked to poorer survival in patients with Mut-<i>TP53</i>, but better survival in patients with WT-<i>TP53</i>. NOX4 is negatively associated with markers of apoptosis and positively with markers of proliferation in patients with Mut-<i>TP53</i>, consistent with their poorer survival. These findings suggest that <i>TP53</i> mutations could “switch” NOX4 from being protective and an indicator of good prognosis to deleterious by promoting programs favoring cancer progression.
first_indexed 2024-03-09T05:44:18Z
format Article
id doaj.art-8b4c0155386d46c8b06ea7264e6cac9b
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-09T05:44:18Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-8b4c0155386d46c8b06ea7264e6cac9b2023-12-03T12:22:35ZengMDPI AGAntioxidants2076-39212021-02-0110223510.3390/antiox10020235Pan-Cancer Analysis Shows <i>TP53</i> Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical OutcomeWei Feng Ma0Howard E. Boudreau1Thomas L. Leto2Laboratory of Clinical Immunology and Microbiology, Molecular Defenses Section, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USALaboratory of Clinical Immunology and Microbiology, Molecular Defenses Section, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USALaboratory of Clinical Immunology and Microbiology, Molecular Defenses Section, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USAPreviously, we have shown TGF-β-induced NOX4 expression is involved in the epithelial-to-mesenchymal transition (EMT), a process critical for cancer metastasis, and that wild-type (WT) and mutant (Mut) p53 have divergent effects on TGF-β induction of NOX4: WT-p53 suppresses whereas Mut-p53 augments NOX4 mRNA and protein production in several tumor cell models. We sought to validate and extend our model by analyzing whole-exome data of primary tumor samples in The Cancer Genome Atlas (TCGA). We constructed a Pan-Cancer dataset from 23 tumor types and explored <i>NOX4</i> expression patterns in relation to EMT and patient survival. NOX4 mRNA levels increase as a function of cancer progression in several cancers and correlate with Mut-p53 mRNA and genes involved in programs of EMT, cellular adhesion, migration, and angiogenesis. Tumor macrophages appear to be a source of NOX2, whose association with genetic programs of cancer progression emulate that of NOX4. Notably, increased <i>NOX4</i> expression is linked to poorer survival in patients with Mut-<i>TP53</i>, but better survival in patients with WT-<i>TP53</i>. NOX4 is negatively associated with markers of apoptosis and positively with markers of proliferation in patients with Mut-<i>TP53</i>, consistent with their poorer survival. These findings suggest that <i>TP53</i> mutations could “switch” NOX4 from being protective and an indicator of good prognosis to deleterious by promoting programs favoring cancer progression.https://www.mdpi.com/2076-3921/10/2/235NOX4NADPH oxidaseEMTp53TCGAbioinformatics
spellingShingle Wei Feng Ma
Howard E. Boudreau
Thomas L. Leto
Pan-Cancer Analysis Shows <i>TP53</i> Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome
Antioxidants
NOX4
NADPH oxidase
EMT
p53
TCGA
bioinformatics
title Pan-Cancer Analysis Shows <i>TP53</i> Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome
title_full Pan-Cancer Analysis Shows <i>TP53</i> Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome
title_fullStr Pan-Cancer Analysis Shows <i>TP53</i> Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome
title_full_unstemmed Pan-Cancer Analysis Shows <i>TP53</i> Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome
title_short Pan-Cancer Analysis Shows <i>TP53</i> Mutations Modulate the Association of NOX4 with Genetic Programs of Cancer Progression and Clinical Outcome
title_sort pan cancer analysis shows i tp53 i mutations modulate the association of nox4 with genetic programs of cancer progression and clinical outcome
topic NOX4
NADPH oxidase
EMT
p53
TCGA
bioinformatics
url https://www.mdpi.com/2076-3921/10/2/235
work_keys_str_mv AT weifengma pancanceranalysisshowsitp53imutationsmodulatetheassociationofnox4withgeneticprogramsofcancerprogressionandclinicaloutcome
AT howardeboudreau pancanceranalysisshowsitp53imutationsmodulatetheassociationofnox4withgeneticprogramsofcancerprogressionandclinicaloutcome
AT thomaslleto pancanceranalysisshowsitp53imutationsmodulatetheassociationofnox4withgeneticprogramsofcancerprogressionandclinicaloutcome